Bulletin
Investor Alert

Market Pulse Archives

July 15, 2021, 2:48 p.m. EDT

Cardiovascular Systems stock drops after CMS proposes payment cuts, but Needham says buy on weakness

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Cardiovascular Systems Inc. (CSII)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Shares of Cardiovascular Systems Inc. /zigman2/quotes/204781833/composite CSII -9.24% , a medical device company focused on treatments for vascular and coronary disease, tumbled 10.2% in afternoon trading, and has dropped 18.1% amid a four-day losing streak. Needham analyst Mike Matson noted that the Centers for Medicare & Medicaid Services' (CMS) proposed physician fee schedule for 2022 includes cuts of about 22% to office-based lab (OBL) payments for peripheral atherectomy. He expects medical societies to oppose to the fee schedule changes. "We do not expect this to have much, if any, impact on [Cardiovascular Systems] even if the cuts happen," Matson said, because he believes the proposed codes leave plenty of profit for the OBL, OBLs account for only about one-fifth of the company's overall sales and the company continued to see strong growth in its OBL business last year even though there were high single-digit cuts to OBL payments. "We are buyers on weakness," Matson said, as he reiterated his buy rating and $50 stock price target. The stock has plunged 19.6% year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.32% has advanced 15.7%.

/zigman2/quotes/204781833/composite
US : U.S.: Nasdaq
$ 21.11
-2.15 -9.24%
Volume: 465,378
Nov. 29, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$943.21 million
Rev. per Employee
$332,017
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,655.27
+60.65 +1.32%
Volume: 2.50B
Nov. 29, 2021 4:57p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.